euro Psycho -Pharmacological study on the role of Saraswata Choorna and Madhuyashtyadi Taila Basti in the management of Post -Stroke depression.

Dr Rajesh Jain0 个研究点目标入组 0 人开始时间: 待定最近更新: 2023年6月26日

试验速览

暂无简介。

•1.The post stroke patients who fulfilled the DSM-V diagnostic criteria for depressive disorder.
•2.Patients ranging between the age of : 40-70 years,
•3.Patients of both Sex; Male/Female,
•4.The patients of Stroke caused after CVA infarct, CVA Hemorrhage will be included.

•1.Mood incongruent delusions or hallucinations, incoherence or marked loosening of associations.
•2.Patients superimposed with schizophrenia, schizophreniform disorders, mania or bipolar disorders or psychotic disorder not otherwise specified.
•3.Generalized anxiety disorders, obsessive compulsive disorders.
•4.Chronic drug abuse, e.g.-barbiturates, etc.
•5.Toxic abuse like alcohol ingestion and withdrawal.
•6.Organic diseases like some diseases of gastrointestinal system (irritable bowel syndrome, colitis), myocardial infarction, neurodegenerative CNS diseases (e.g. Alzheimerâ??s disease), Hypothyroidism & hyperthyroidism and systemic diseases like Rheumatoid arthritis and other connective tissue disorders etc.
•7.The diabetic patients with or without uncontrolled blood sugar level, or under the hypoglycaemic drugs.

发起方

Dr Rajesh Jain